National Bank of Canada’s Moderna MRNA Stock Holding History

National Bank of Canada’s Portfolio MRNA Stock Details MRNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$86.4M	Sell	12,340 -2,200	-15%	-$114K	0.06%	234
2026 Q1	$73.9M	Sell	14,540 -5,460	-27%	-$255K	0.07%	227
2025 Q4	$59M	Sell	20,000 -8,468	-30%	-$230K	0.05%	280
2025 Q3	$73.5M	Buy	28,468 +20,000	+236%	+$558K	0.07%	221
2025 Q2	$23.4M	Hold	8,468	–	–	0.02%	507
2025 Q1	$24M	Buy	+8,468	New	+$301K	0.03%	477
2023 Q4	–	Sell	-5,500	Closed	-$56.8M	–	2828
2023 Q3	$56.8M	Buy	+5,500	New	+$614K	0.09%	210
2023 Q1	–	Sell	-1	Closed	-$18K	–	2804
2022 Q4	$18K	Hold	1	–	–	﹤0.01%	2031
2022 Q3	$12K	Hold	1	–	–	﹤0.01%	2142
2022 Q2	$14K	Sell	1 -999	-100%	-$143K	﹤0.01%	2175
2022 Q1	$17.2M	Buy	+1,000	New	+$168K	0.05%	325

Other funds holding MRNA

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

BPC

Banque Pictet & Cie Geneva 73, Switzerland $16B AUM 29.1% 1-Year Est. Return

Merck & Co Kenilworth, New Jersey $526M AUM 175.27% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

DLA

Douglas Lane & Associates New York $7.37B AUM 21.9% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

LIM

Lingotto Investment Management London, United Kingdom $4.67B AUM 70.24% 1-Year Est. Return

National Bank of Canada's MRNA Position: Q2 2026 in Review

National Bank of Canada reduced its Moderna (MRNA) stake by 22% in Q2 2026, selling an estimated $20.3M and leaving 1,424,802 shares worth $99.8M. The position accounts for 0.07% of the portfolio, ranked #208.

National Bank of Canada first reported a position in MRNA in Q4 2021 and has held it in 19 quarters since. 435 funds tracked by Wall St. Rank hold MRNA as of Q2 2026.

National Bank of Canada held 1,424,802 shares of Moderna worth $99.8M as of Q2 2026.
National Bank of Canada sold 392,199 Moderna shares in Q2 2026, an estimated $20.3M.
Moderna made up 0.07% of National Bank of Canada's portfolio in Q2 2026, its #208 holding.
National Bank of Canada first reported a position in Moderna in Q4 2021 and has held it in 19 quarters since.
435 funds tracked by Wall St. Rank held Moderna as of Q2 2026.

Based on National Bank of Canada's 13F filing for Q2 2026, filed 10 Aug 2026.